US Patent 11458134 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Takeda Pharmaceutical

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Takeda Pharmaceutical

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

VIDEO(s)

VIDEO

VIDEO

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 1859 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
1859 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

54 All APIs, 32 USDMF, 6 CEP/COS, 5 JDMF, 9 KDMF, 14 NDC API

54 All APIs
32 USDMF
6 CEP/COS
5 JDMF
9 KDMF
14 NDC API

DEVELOPMENTS

1225 Drugs in Development

1225 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1381 FDF Dossiers, 124 FDA Orange Book, 1005 Europe, 95 Canada, 110 Australia, 45 South Africa, 2 Listed Dossiers

1381 FDF Dossiers
124 FDA Orange Book
1005 Europe
95 Canada
110 Australia
45 South Africa
2 Listed Dossiers

INSPECTIONS & REGISTRATIONS

104 FDA, 4 EDQM, 2 Third-Party Audit

104 FDA
4 EDQM
2 Third-Party Audit

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4TAKEDA PHARMS USA

filter Patent Number Reset all filters

4 All

01 411458134

API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42027-06-15

01

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

BioProcess International US West

Not Confirmed

TAKEDA PHARMS USA

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-15

VORTIOXETINE HYDROBROMIDE

US Patent Number : 11458134

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204447

Patent Use Code : U-3463

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

BioProcess International US West

Not Confirmed

TAKEDA PHARMS USA

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-15

VORTIOXETINE HYDROBROMIDE

US Patent Number : 11458134

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204447

Patent Use Code : U-3463

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

BioProcess International US West

Not Confirmed

TAKEDA PHARMS USA

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-15

VORTIOXETINE HYDROBROMIDE

US Patent Number : 11458134

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204447

Patent Use Code : U-3463

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

TAKEDA PHARMS USA

VORTIOXETINE HYDROBROMIDE

BioProcess International US West

Not Confirmed

TAKEDA PHARMS USA

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-15

VORTIOXETINE HYDROBROMIDE

US Patent Number : 11458134

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204447

Patent Use Code : U-3463

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.